Advertisement
Canada markets closed
  • S&P/TSX

    21,554.86
    -26.44 (-0.12%)
     
  • S&P 500

    5,464.62
    -8.55 (-0.16%)
     
  • DOW

    39,150.33
    +15.53 (+0.04%)
     
  • CAD/USD

    0.7303
    -0.0000 (-0.01%)
     
  • CRUDE OIL

    80.48
    -0.25 (-0.31%)
     
  • Bitcoin CAD

    87,116.92
    -919.68 (-1.04%)
     
  • CMC Crypto 200

    1,310.33
    -50.00 (-3.68%)
     
  • GOLD FUTURES

    2,334.20
    +3.00 (+0.13%)
     
  • RUSSELL 2000

    2,022.03
    +4.64 (+0.23%)
     
  • 10-Yr Bond

    4.2570
    +0.0030 (+0.07%)
     
  • NASDAQ futures

    20,014.25
    +31.50 (+0.16%)
     
  • VOLATILITY

    13.20
    -0.08 (-0.60%)
     
  • FTSE

    8,237.72
    -34.74 (-0.42%)
     
  • NIKKEI 225

    38,596.47
    -36.53 (-0.09%)
     
  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

Could This Move by Johnson & Johnson Equal Billions for Moderna?

Could This Move by Johnson & Johnson Equal Billions for Moderna?

What does big pharma Johnson & Johnson (NYSE: JNJ) have in common with biotech Moderna (NASDAQ: MRNA)? Last week, however, Johnson & Johnson said it would discontinue its adult RSV program. Could the J&J news eventually translate into billions of dollars for Moderna?